Abstract:Background: Several studies have pointed to the critical role of gut microbiota (GM) and their metabolites in Hirschsprung disease (HSCR) pathogenesis. However, the detailed causal relationship between GM and HSCR remains unknown. Methods: In this study, we used two-sample Mendelian randomization (MR) analysis to investigate the causal relationship between GM and HSCR, based on the MiBioGen Consortium's genome-wide association study (GWAS) and the GWAS Catalog's HSCR data. Reverse MR analysis was performed subsequently, and the sensitivity analysis, Cochran's Q-test, MR pleiotropy residual sum, outlier (MR-PRESSO), and the MR-Egger intercept were used to analyze heterogeneity or horizontal pleiotropy. 16S rDNA sequencing and targeted mass spectrometry were developed for initial validation. Results: In the forward MR analysis, inverse-variance weighted (IVW) estimates suggested that Eggerthella (OR: 2.66, 95%CI: 1.23–5.74, p = 0.01) was a risk factor for HSCR, while Peptococcus (OR: 0.37, 95%CI: 0.18–0.73, p = 0.004), Ruminococcus2 (OR: 0.32, 95%CI: 0.11–0.91, p = 0.03), Clostridiaceae1 (OR: 0.22, 95%CI: 0.06–0.78, p = 0.02), Mollicutes RF9 (OR: 0.27, 95%CI: 0.09–0.8, p = 0.02), Ruminococcaceae (OR: 0.16, 95%CI: 0.04–0.66, p = 0.01), and Paraprevotella (OR: 0.45, 95%CI: 0.21–0.98, p = 0.04) were protective factors for HSCR, which had no heterogeneity or horizontal pleiotropy. However, reverse MR analysis showed that HSCR (OR: 1.02, 95%CI: 1–1.03, p = 0.049) is the risk factor for Eggerthella. Furthermore, some of the above microbiota and short-chain fatty acids (SCFAs) were altered in HSCR, showing a correlation. Conclusion: Our analysis established the relationship between specific GM and HSCR, identifying specific bacteria as protective or risk factors. Significant microbiota and SCFAs were altered in HSCR, underlining the importance of further study and providing new insights into the pathogenesis and treatment.

Serum Metabolomic Signatures of Hirschsprung's Disease Based on GC-MS and LC-MS

Comparative Proteomics of Hirschsprung's Disease

Comparative Proteomic Profiles of the Normal and Aganglionic Hindgut in Human Hirschsprung Disease.

Comparative Study of Hsp27, GSK3β, Wnt1 and PRDX3 in Hirschsprung's Disease

The Single Nucleotide Polymorphisms in Smad-interacting Protein 1 Gene Contribute to Its Ectopic Expression and Susceptibility in Hirschsprung's Disease.

Hirschsprung’s disease: key microRNAs and target genes

Microarray Expression Profiling of Dysregulated Long Non-Coding Rnas in Hirschsprung'S Disease Reveals Their Potential Role in Molecular Diagnosis

Detection and Significance of Serum Protein Marker of Hirschsprung Disease

Proteomic Analysis Provides a New Sight Into the CRABP1 Expression in the Pathogenesis of Hirschsprung Disease

Study of the Effect of Mir-124 and the Sox9 Target Gene in Hirschsprung'S Disease

Polymorphisms and Expression of the Wnt8a Gene in Hirschsprung'S Disease

Comprehensive characterization of the genetic landscape of familial Hirschsprung's disease

Association between gut microbiota and Hirschsprung disease: a bidirectional two-sample Mendelian randomization study

Expression Patterns of Dishevelled-2 in Different Colon Tissue Segments in Hirschsprung's Disease.

A Pilot Study: Transcriptional Profiling, Functional Analysis, and Organoid Modeling of Intestinal Mucosa in Hirschsprung Disease

Expression of Dishevelled Gene in Hirschsprung's Disease.

Bioinformatics Prediction for Network-Based Integrative Multi-Omics Expression Data Analysis in Hirschsprung Disease

Weighted gene co-expression network analysis and CIBERSORT screening of key genes related to m6A methylation in Hirschsprung's disease

Serum Metabolomics Reveals the Effectiveness of Human Placental Mesenchymal Stem Cell Therapy for Crohn's Disease

Weighted Gene Coexpression Network Analysis Reveals the Critical lncRNAs and mRNAs in Development of Hirschsprung's Disease

Serum metabolite profiling of human colorectal cancer using GC-TOFMS and UPLC-QTOFMS.